Literature DB >> 21439658

C-reactive protein (CRP): an important diagnostic and prognostic tool in nursing-home-associated pneumonia.

Zeev Arinzon1, Alexander Peisakh, Samuel Schrire, Yitshal Berner.   

Abstract

Pneumonia is the second most common infection in long term care (LTC) residents and is a leading cause of death from infection in those groups of patients. Atypical presentations and fewer presenting signs and symptoms in older patients complicate diagnosis and delay initiation of adequate treatment. The aim of this study was to compare laboratory CRP levels to pneumonia severity scores, in prediction of short-term death from pneumonia. Diagnosis of pneumonia was performed according to the criteria of McGeer for the identification of pneumonia at an LTC facility. The severities of pneumonia and mortality prediction were assessed by three indices: PSI (pneumonia severity index), Missouri study index and the nursing home associated pneumonia (NHAP) severity index. A strong positive correlation was found between CRP levels and PSI (r=0.445, p<0.001), Missouri study index (r=0.315, p<0.001) and NHAP severity index (r=0.246, p=0.002). The initial values of CRP were significantly higher in patients with short term mortality and positively correlated with rate of death (r=0.493, p<0.001). By multivariate regression analysis, the variables that were independently and significantly associated with the rate of death included presence and duration of fever, respiratory rate, serum CRP and albumin levels, lymphocyte count, number of comorbid diseases, CHF, and DM (the R2 was 0.711 and 0.685 when adjusted). Because presentation of nursing home acquired pneumonia is not specific, it is suggested that CRP should be performed in every patient with a suspicion of pneumonia.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439658     DOI: 10.1016/j.archger.2011.01.006

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  7 in total

1.  [Clinical significance of hypersensitive C-reactive protein, fribrinogen and D-dimmer in connective tissue disease-related interstitial lung disease].

Authors:  Si-Jie Yuan; Hai-Ting Xie; Zhong-Li Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

2.  Correlation between serum levels of C-reactive protein and infant pneumonia: A meta-analysis.

Authors:  Xiao Xiao; Long Xue; Hui-Lin Sheng; Zhi-Hui Xiao
Journal:  Exp Ther Med       Date:  2015-04-08       Impact factor: 2.447

3.  Correlation between serum levels of C-reactive protein and neonatal pneumonia: A protocol for systematic review and meta-analysis.

Authors:  Xiaowen Li; Zhong Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 4.  Predictors of mortality for nursing home-acquired pneumonia: a systematic review.

Authors:  Naveen Dhawan; Naushira Pandya; Michael Khalili; Manuel Bautista; Anurag Duggal; Jaya Bahl; Vineet Gupta
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

5.  Naso- and oropharyngeal bacterial carriage in nursing home residents: Impact of multimorbidity and functional impairment.

Authors:  Anja Kwetkat; Wolfgang Pfister; Diana Pansow; Mathias W Pletz; Cornel C Sieber; Heike Hoyer
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

6.  Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE): study design of a cluster randomized controlled trial.

Authors:  Tjarda M Boere; Laura W van Buul; Rogier M Hopstaken; Ruth B Veenhuizen; Maurits W van Tulder; Jochen W L Cals; Theo J M Verheij; Cees M P M Hertogh
Journal:  BMC Health Serv Res       Date:  2020-02-27       Impact factor: 2.655

7.  Nursing assistants: "he seems to be ill" - a reason for nurses to take action: validation of the Early Detection Scale of Infection (EDIS).

Authors:  P Tingström; A Milberg; N Rodhe; J Ernerud; E Grodzinsky; M Sund-Levander
Journal:  BMC Geriatr       Date:  2015-10-12       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.